GAFFX
Price
$82.92
Change
+$0.81 (+0.99%)
Updated
Jul 3 closing price
Net Assets
322.86B
KLCCX
Price
$11.43
Change
+$0.15 (+1.33%)
Updated
Jul 3 closing price
Net Assets
1.25B
Interact to see
Advertisement

GAFFX vs KLCCX

Header iconGAFFX vs KLCCX Comparison
Open Charts GAFFX vs KLCCXBanner chart's image
American Funds Growth Fund of Amer F3
Price$82.92
Change+$0.81 (+0.99%)
VolumeN/A
Net Assets322.86B
Federated Hermes Kaufmann Large Cap C
Price$11.43
Change+$0.15 (+1.33%)
VolumeN/A
Net Assets1.25B
GAFFX vs KLCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GAFFX vs. KLCCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and KLCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 323B vs. KLCCX (1.25B). GAFFX pays higher dividends than KLCCX: GAFFX (0.61) vs KLCCX (0.00). GAFFX was incepted earlier than KLCCX: GAFFX (8 years) vs KLCCX (18 years). KLCCX (1.96) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. KLCCX (18.00). KLCCX has a lower initial minimum investment than GAFFX: KLCCX (1500) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 11.26 vs. KLCCX (-28.34). GAFFX return over 5 years is better than : 51.33 vs. KLCCX (-57.71).
GAFFXKLCCXGAFFX / KLCCX
Total Expense Ratio0.301.8916%
Annual Report Gross Expense Ratio0.301.9615%
Fund Existence8 years18 years-
Gain YTD11.3478.857128%
Front LoadN/AN/A-
Min. Initial Investment1000000150066,667%
Min. Initial Investment IRAN/AN/A-
Net Assets323B1.25B25,799%
Annual Yield % from dividends0.610.00-
Returns for 1 year11.26-28.34-40%
Returns for 3 years60.93-44.27-138%
Returns for 5 years51.33-57.71-89%
Returns for 10 yearsN/A-37.68-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVCT0.08N/A
+5.27%
Provectus Biopharmaceuticals, Inc.
TATYY30.030.13
+0.43%
Tate & Lyle, PLC
EVAHF0.08N/A
N/A
EGF THERAMED HEALTH CORP.
SSDOF18.17N/A
N/A
Shiseido Company, Ltd.
JBPHF0.29N/A
N/A
Jacobio Pharmaceuticals Group Co Ltd.